New Delhi, Oct 24 (PTI) Drug firm Lupin on Friday said it has launched a generic medication to treat urea cycle disorders in the US.

The company has launched an authorised generic version of Ravicti (Glycerol Phenylbutyrate) oral liquid, 1.1g/mL, in the US, the Mumbai-based firm said in a statement.

Glycerol Phenylbutyrate Oral Liquid, 1.1g/mL, is indicated for chronic management of patients with urea cycle disorders (UCDs) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone.

Shares of the company were trading 0.37 per cent down at 1,932.85 apieceon BSE. PTI MSS DR DR (This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI )

See Full Page